ACST: Acasti Pharma Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 25.19
Enterprise Value ($M) 6.65
Book Value ($M) 64.68
Book Value / Share 6.88
Price / Book 0.39
NCAV ($M) 15.38
NCAV / Share 1.64
Price / NCAV 1.64

Profitability (mra)
Return on Invested Capital (ROIC) -0.60
Return on Assets (ROA) -0.49
Return on Equity (ROE) -0.57

Liquidity (mrq)
Quick Ratio 15.19
Current Ratio 15.19

Balance Sheet (mrq) ($M)
Current Assets 26.88
Assets 76.19
Liabilities 11.51
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-09 13G Hirschman Orin 6.00
02-13 13G Bank Of America Corp /de/ 5.30

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-06-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 2,366 4,468 52.95
2024-04-30 2,242 10,392 21.57
2024-04-29 1,800 2,209 81.48
2024-04-26 991 306 323.86

(click for more detail)

Similar Companies
ABVC – ABVC BioPharma, Inc. ACB – Aurora Cannabis Inc.
ACHV – Achieve Life Sciences, Inc. ACXP – Acurx Pharmaceuticals, Inc.
ADIL – Adial Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io